Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

NCT00077376 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: ixabepilone
DRUG: carboplatin
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)